Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs

scientific article published on 31 May 2018

Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2018.05.019
P698PubMed publication ID29778519

P50authorBo T. HansenQ47368348
Maria HortlundQ57021947
P2093author name stringSusanne K Kjaer
Joakim Dillner
Mari Nygård
Christian Munk
Kai-Li Liaw
Camilla Lagheden
P2860cites workDifferent Challenges in Eliminating HPV16 Compared to Other Types: A Modeling StudyQ38599579
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.Q39281387
Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination programQ42220415
Modelling patterns of clearance of HPV-16 infection and vaccination efficacyQ43946877
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmesQ69899836
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceQ26745696
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisQ28084924
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional studyQ28245583
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasiaQ28296557
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenQ30052389
Human papillomavirus vaccination: the population impactQ33806566
Role of herd immunity in determining the effect of vaccines against sexually transmitted diseaseQ34380787
Cervical cancer: prevention, diagnosis, and therapeuticsQ34385040
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.Q36734952
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccinationQ37078556
Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional studyQ37839810
Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring studyQ37843055
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 yearsQ38383530
Registry-based assessment of the status of cervical screening in SwedenQ38408579
P433issue26
P407language of work or nameEnglishQ1860
P1104number of pages10
P304page(s)3820-3829
P577publication date2018-05-31
P1433published inVaccineQ7907941
P1476titleDecline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs
P478volume36

Reverse relations

cites work (P2860)
Q90629815An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
Q98175047Authors' reply
Q97565439Evidence of HPV vaccination efficacy comes from more than clinical trials
Q61805846Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study
Q90098604Letter to the editor
Q78879005Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis